Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
72.01Price to Sales
VS
Market
Sector
Industry
History
$ 6.49Close
$ 2 - $ 6.78 52-Week Range
Ticker Information
Ticker
RLAYCompany Name
RELAY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRELAY THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RLAY - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 601.72M | 72.01 | $ 8.36M |
| 3/31/2025 | $ 569.2M | 74.12 | $ 7.68M |
| 12/31/2024 | $ 635.71M | 63.53 | $ 10.01M |
| 9/30/2024 | $ 1.05B | 104.55 | $ 10.01M |
| 6/30/2024 | $ 962.67M | 27.34 | $ 35.21M |
| 3/31/2024 | $ 939.81M | 26.6 | $ 35.33M |
| 12/31/2023 | $ 1.39B | 54.28 | $ 25.55M |
| 9/30/2023 | $ 912.19M | 35.36 | $ 25.8M |
| 6/30/2023 | $ 1.36B | 1.45K | $ 942K |
| 3/31/2023 | $ 1.36B | 1.15K | $ 1.19M |
Key Performance Insights, Last 5 Years
- RELAY THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, RELAY THERAPEUTICS INC's average P/S has been 476.5.
- The median P/S for RELAY THERAPEUTICS INC during this period was 72.01
- RELAY THERAPEUTICS INC reached its highest P/S over the past 5 years at 1.53K.
- The lowest P/S recorded by RELAY THERAPEUTICS INC in the same timeframe 26.6
RELAY THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for RELAY THERAPEUTICS INC is calculated as follows: Market Cap [ $ 4.29B ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] RLAY - Price to Sales, Last 5 years
26.6
Minimum
Mar 31, 2024
1.53K
Maximum
Dec 31, 2022
476.5
Average
72.01
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |